4.6 Review

Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens

期刊

FRONTIERS IN MICROBIOLOGY
卷 14, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2023.1170418

关键词

phage-encoded lysins; antimicrobial resistance; Gram-negative bacteria; Acinetobacter baumannii; Pseudomonas aeruginosa; Enterobacteriaceae

向作者/读者索取更多资源

The indiscriminate use of antibiotics has led to a rise in antimicrobial resistance (AMR), posing a serious global threat. Natural or engineered phage-encoded lysins (enzybiotics) show promise as alternative antibacterial agents. While there have been advancements in using lysins against Gram-positive bacteria, the outer membrane of Gram-negative bacteria presents a challenge. This review discusses the potential and challenges of lysins, particularly for priority Gram-negative pathogens, and the regulatory framework for developing them as therapeutics.
Antibiotics remain the frontline agents for treating deadly bacterial pathogens. However, the indiscriminate use of these valuable agents has led to an alarming rise in AMR. The antibiotic pipeline is insufficient to tackle the AMR threat, especially with respect to the WHO critical category of priority Gram-negative pathogens, which have become a serious problem as nosocomial and community infections and pose a threat globally. The AMR pandemic requires solutions that provide novel antibacterial agents that are not only effective but against which bacteria are less likely to gain resistance. In this regard, natural or engineered phage-encoded lysins (enzybiotics) armed with numerous features represent an attractive alternative to the currently available antibiotics. Several lysins have exhibited promising efficacy and safety against Gram-positive pathogens, with some in late stages of clinical development and some commercially available. However, in the case of Gram-negative bacteria, the outer membrane acts as a formidable barrier; hence, lysins are often used in combination with OMPs or engineered to overcome the outer membrane barrier. In this review, we have briefly explained AMR and the initiatives taken by different organizations globally to tackle the AMR threat at different levels. We bring forth the promising potential and challenges of lysins, focusing on the WHO critical category of priority Gram-negative bacteria and lysins under investigation for these pathogens, along with the challenges associated with developing them as therapeutics within the existing regulatory framework.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据